These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29244961)

  • 21. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
    Abd El-Haleim EA; Bahgat AK; Saleh S
    Eur J Pharmacol; 2016 Feb; 773():59-70. PubMed ID: 26825546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor γ with Excellent Effect on Insulin Resistance and Type 2 Diabetes.
    Liu HJ; Zhang CY; Song F; Xiao T; Meng J; Zhang Q; Liang CL; Li S; Wang J; Zhang B; Liu YR; Sun T; Zhou HG
    J Pharmacol Exp Ther; 2015 Jun; 353(3):573-81. PubMed ID: 25876909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid drug combination: Anti-diabetic treatment of type 2 diabetic Wistar rats with combination of ellagic acid and pioglitazone.
    Nankar RP; Doble M
    Phytomedicine; 2017 Dec; 37():4-9. PubMed ID: 29103827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
    Ge J; Miao JJ; Sun XY; Yu JY
    J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo.
    Lee BH; Hsu WH; Chang YY; Kuo HF; Hsu YW; Pan TM
    Free Radic Biol Med; 2012 Dec; 53(11):2008-16. PubMed ID: 23022408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.
    Ohga S; Shikata K; Yozai K; Okada S; Ogawa D; Usui H; Wada J; Shikata Y; Makino H
    Am J Physiol Renal Physiol; 2007 Apr; 292(4):F1141-50. PubMed ID: 17190910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D deficiency impairs glucose-stimulated insulin secretion and increases insulin resistance by reducing PPAR-γ expression in nonobese Type 2 diabetic rats.
    Park S; Kim DS; Kang S
    J Nutr Biochem; 2016 Jan; 27():257-65. PubMed ID: 26522682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats.
    Yamagishi S; Ogasawara S; Mizukami H; Yajima N; Wada R; Sugawara A; Yagihashi S
    J Neurochem; 2008 Jan; 104(2):491-9. PubMed ID: 17995925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
    Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
    Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tangduqing Granules Attenuate Insulin Resistance and Abnormal Lipid Metabolism through the Coordinated Regulation of PPAR
    Zhang Q; Huang Y; Li X; Liu H; He B; Wang B; Ma Y; Zhou X; Liu Y; Wu S
    J Diabetes Res; 2019; 2019():7403978. PubMed ID: 31019978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PPARγ activation alters fatty acid composition in adipose triglyceride, in addition to proliferation of small adipocytes, in insulin resistant high-fat fed rats.
    Sato D; Oda K; Kusunoki M; Nishina A; Takahashi K; Feng Z; Tsutsumi K; Nakamura T
    Eur J Pharmacol; 2016 Feb; 773():71-7. PubMed ID: 26825545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic responses, PPAR-γ and TNF-α gene expression in type2 diabetic rats subsequent vanadyl sulfate treatment.
    Aghadavod E; Manteghie N; Taghizadeh M; Talaei SA; Mirhashemi SM
    Pak J Pharm Sci; 2024 Jan; 37(1):79-84. PubMed ID: 38741403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of a type 2 diabetes rat model induced by high-fat diet feeding with low-dose streptozotocin injection.
    Guo XX; Wang Y; Wang K; Ji BP; Zhou F
    J Zhejiang Univ Sci B; 2018 Jul; 19(7):559-569. PubMed ID: 29971994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selenite exacerbates hepatic insulin resistance in mouse model of type 2 diabetes through oxidative stress-mediated JNK pathway.
    Zhou J; Xu G; Bai Z; Li K; Yan J; Li F; Ma S; Xu H; Huang K
    Toxicol Appl Pharmacol; 2015 Dec; 289(3):409-18. PubMed ID: 26522834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation.
    Collino M; Aragno M; Castiglia S; Miglio G; Tomasinelli C; Boccuzzi G; Thiemermann C; Fantozzi R
    Br J Pharmacol; 2010 Aug; 160(8):1892-902. PubMed ID: 20233219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
    Ding SY; Shen ZF; Chen YT; Sun SJ; Liu Q; Xie MZ
    Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of liver histone deacetylase 3 contributes to high-fat-diet-induced metabolic syndrome by suppressing the PPAR-γ and LXR-α-pathways in E3 rats.
    Li D; Wang X; Ren W; Ren J; Lan X; Wang F; Li H; Zhang F; Han Y; Song T; Holmdahl R; Lu S
    Mol Cell Endocrinol; 2011 Sep; 344(1-2):69-80. PubMed ID: 21763752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaempferia parviflora Ethanol Extract, a Peroxisome Proliferator-Activated Receptor γ Ligand-binding Agonist, Improves Glucose Tolerance and Suppresses Fat Accumulation in Diabetic NSY Mice.
    Ochiai M; Takeuchi T; Nozaki T; Ishihara KO; Matsuo T
    J Food Sci; 2019 Feb; 84(2):339-348. PubMed ID: 30726580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidiabetic effects of Morus alba fruit polysaccharides on high-fat diet- and streptozotocin-induced type 2 diabetes in rats.
    Jiao Y; Wang X; Jiang X; Kong F; Wang S; Yan C
    J Ethnopharmacol; 2017 Mar; 199():119-127. PubMed ID: 28163112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.